2 completed, 1 terminated. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Biosense Webster EMEA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| European Carto® XP REgistry for Validating Specialized CFAE SOftware RF ablation, using specialized CFAE software - Atrial Fibrillation | Completed | Biosense Webster EMEA | 206 | 2008-09-01 | 2016-02-08 | |
| FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT) RF ablation, anti-arrhythmic drug therapy - Atrial Fibrillation | Phase 3 | Completed | Biosense Webster EMEA | 40 | 2005-09-01 | 2025-02-03 |
| CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation RF ablation, Antiarrhythmic drugs - Atrial Fibrillation | Phase 4 | Terminated | Biosense Webster EMEA | 129 | 2004-12-01 | 2025-02-04 |
France (1) · Germany (1) · Hungary (1)
Agustin Bortone, MD (1) · Ahmed Abdelaal, MD (1) · Armin Luik, MD (1) · Boris Schmidt, MD (1) · Bruno Cauchemez, MD (1) · Emanuele Bertaglia, MD (1) · F. Gaita, Prof. (1) · Fabrice Extramiana, MD (1) · Franck Raczka, MD (1) · Giuseppe Stabile, MD (1) · Jean-Paul Albenque, MD (1) · Julien Seitz, MD (1)